Atara Biotherapeutics Inc
NASDAQ:ATRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
N
|
New Gold Inc
XMUN:32N
|
CA |
|
J
|
Julius Baer Gruppe AG
SIX:BAER
|
CH |
|
Daiichi Sankyo Co Ltd
F:D4S
|
JP |
|
R
|
Renault SA
F:RNL1
|
FR |
|
Sogeclair SA
F:2U0
|
FR |
|
Figs Inc
NYSE:FIGS
|
US |
|
M
|
Mission Ready Solutions Inc
XTSX:MRS
|
CA |
|
R
|
Reckitt Benckiser Group PLC
XMUN:3RB
|
UK |
|
S
|
Salvatore Ferragamo SpA
DUS:S9L
|
IT |
|
Lonza Group AG
F:LO3
|
CH |
|
F
|
Fortune Brands Innovations Inc
SWB:2FB
|
US |
|
G
|
Gen Digital Inc
DUS:SYM
|
US |
|
Siemens Healthineers AG
F:SHL
|
DE |
|
Toyo Tire Corp
F:TYR
|
JP |
|
D
|
D R Horton Inc
F:HO2
|
US |
|
P
|
Panasonic Holdings Corp
XBER:MAT1
|
JP |
|
S
|
Sompo Holdings Inc
XBER:ANK
|
JP |
|
LNA Sante SA
F:2N3
|
FR |
Wall St Price Targets
ATRA Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ATRA is 13.94 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATRA's stock price target?
Price Target
13.94
USD
According to Wall Street analysts, the average 1-year price target for
ATRA is 13.94 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-53%
The compound annual growth rate for Revenue over the next 3 years is -53%.
What is the Gross Profit forecast for Atara Biotherapeutics Inc?
Projected CAGR
-51%
The compound annual growth rate for Gross Profit over the next 3 years is -51%.